AUG Therapeutics is a clinical-stage biotechnology company specializing in developing pharmaceuticals for rare pediatric and orphan diseases. AUG is on a conscientious mission to put patients suffering from rare and neglected disease and their families as our first priority. Our relentless efforts are dedicated to advancing patient care and addressing the unique challenges presented by these conditions.